Priska Kaufmann

11PUBLICATIONS
12CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPharmacogenomicsCharacterisation of biological macromoleculesBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 27, 2024
Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A.

Massimo Magliocca, Benjamin Berger, Vincent Lemoine

|Mar 13, 2024
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects.

Isabelle Zenklusen, Jasper Dingemanse, Christian Reh

|Oct 19, 2023
Effect of Daridorexant on the Pharmacokinetics of P-Glycoprotein Substrate Dabigatran Etexilate and Breast Cancer Resistance Protein Substrate Rosuvastatin in Healthy Subjects.

Marion Anliker-Ort, Jasper Dingemanse, Luboš Janů

|Oct 06, 2023
Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects.

Benjamin Berger, Priska Kaufmann, Matthias Berse

|Jul 20, 2023
Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a<sub>1</sub> receptor) antagonist.

Marion Anliker-Ort, Chih-Hsuan Hsin, Andreas Krause

|Apr 12, 2023
Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT-1014-6470 in vitro and in vivo.

Marion Anliker-Ort, Jasper Dingemanse, Stephane Delahaye

Pageof 2

Frequent Collaborators

11 joint publications

Jasper Dingemanse

6 joint publications

Marion Ort

4 joint publications

Benjamin Berger

2 joint publications

Muriel Richard